Nektar Therapeutics (India) Private Limited

Biopharmaceutical company conducting research and development for various therapeutic areas.

2005 | Hyderabad, Telangana (India) | Active
Last Updated:

Nektar Therapeutics (India) Profile

Key Indicators

  • Authorised Capital ₹ 30.00 Cr
  • Paid Up Capital ₹ 29.39 Cr
  • Company Age 20 Year, 10 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 22.60%
  • Profit Growth -364.93%
  • Ebitda 10.67%
  • Net Worth -16.12%
  • Total Assets 3.67%

About Nektar Therapeutics (India)

Nektar Therapeutics (India) Private Limited (NTIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 16 May 2005 and has a history of 20 years. Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 29.39 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Nektar Therapeutics (India) Private Limited India is Phaneendra Modali as COMPANY SECRETARY. Uday Yemmanuru, Mark Wilson, and Robert Bacci serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24239TG2005FTC046253

  • Company No.

    046253

  • Company Classification

    Private Limited Foreign Company Incorporated In India

  • Incorporation Date

    16 May 2005

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

What products or services does Nektar Therapeutics (India) Private Limited offer?

Nektar Therapeutics (India) Private Limited offers a wide range of products and services, including .

Company report

Nektar Therapeutics (India) Private Limited

Explore comprehensive data for Nektar Therapeutics (India) Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Nektar Therapeutics (India)?

Executive Team (1)

NameDesignationAppointment DateStatus
Phaneendra Modali Company Secretary16-Jul-2018Current

Board Members (3)

NameDesignationAppointment DateStatus
Uday Yemmanuru Country flag representing In Director 25-Mar-2024Current
Mark Wilson Country flag representing Us Director 19-Mar-2019Current
Robert Bacci Director 18-Jun-2024Current

Financial Performance of Nektar Therapeutics (India).

Nektar Therapeutics (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.6% increase. The company also saw a substantial fall in profitability, with a 364.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.12%.

Nektar Therapeutics (India) revenue growth over time
Nektar Therapeutics (India) profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
22.60%
Revenue from Operations
17.04%
Total Assets
3.67%
Profit or Loss
-364.93%
Net Worth
-16.12%
EBITDA
10.67%

What is the Ownership and Shareholding Structure of Nektar Therapeutics (India)?

In 2021, Nektar Therapeutics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Nektar Therapeutics (India)?

Nektar Therapeutics (India) has a workforce of 3 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Nektar Therapeutics (India) Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nektar Therapeutics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nektar Therapeutics (India)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Nektar Therapeutics (India)

Recent activity within the organization

  • Annual General Meeting

    Nektar Therapeutics (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Director Appointment

    Robert Michael Bacci was appointed as a Director was appointed as a Director on 18 Jun 2024 & has been associated with this company since 11 months 8 days .

  • Balance Sheet

    Nektar Therapeutics (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Director Appointment

    Uday Chandra Yemmanuru was appointed as a Director was appointed as a Director on 25 Mar 2024 & has been associated with this company since 1 year 2 months .

  • Director Appointment

    Mark Andrew Wilson was appointed as a Director was appointed as a Director on 19 Mar 2019 & has been associated with this company since 6 years 2 months .

  • Director Appointment

    Phaneendra Modali was appointed as a Company Secretary was appointed as a Company Secretary on 16 Jul 2018 & has been associated with this company since 6 years 10 months .

Frequently asked questions

  • What is the Incorporation or founding date of Nektar Therapeutics (India) Private Limited?

    Nektar Therapeutics (India) Private Limited was incorporated on 16 May 2005.

  • What is authorized share capital and paid-up capital of Nektar Therapeutics (India) Private Limited?

    The authorized share capital of Nektar Therapeutics (India) Private Limited is ₹ 30.00 Cr and paid-up capital is ₹ 29.39 Cr.

  • Who are the current board members & directors of Nektar Therapeutics (India) Private Limited?

    Currently 4 directors are associated with Nektar Therapeutics (India) Private Limited.

    • Uday Chandra Yemmanuru
    • Mark Andrew Wilson
    • Robert Michael Bacci
    • Phaneendra Modali

  • What is the registered address of Nektar Therapeutics (India) Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Nektar Therapeutics (India) Private Limited is Plot No. 105/1, P T Colony Tirumalgherry India, Tirumalagiri, Telangana, 500015.

  • What is the corporate identification number (CIN) and company number of Nektar Therapeutics (India) Private Limited?

    The corporate identification number (CIN) of Nektar Therapeutics (India) Private Limited is U24239TG2005FTC046253 and the company number is 046253 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Nektar Therapeutics (India) Private Limited?

    The Official website of Nektar Therapeutics (India) Private Limited is https://www.nektar.com

  • What has been the recent revenue trend for Nektar Therapeutics (India) Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Nektar Therapeutics (India) Private Limited has risen by 22.60%.

  • How many employees does Nektar Therapeutics (India) Private Limited currently have?

    As Per 2022 financial reports, 3 employees are currently employed by Nektar Therapeutics (India) Private Limited.

  • What change has been observed in the net worth of Nektar Therapeutics (India) Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Nektar Therapeutics (India) Private Limited has experienced an downturn of -16.12%.

  • When was the last Balance Sheet of Nektar Therapeutics (India) Private Limited filed with the ROC?

    The most recent Balance Sheet for Nektar Therapeutics (India) Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharma Contract R&D